Russian Ministry ready to support pharmaceutical equipment manufacturers
15 March 2017
Vasily Osmakov, Deputy Minister of Industry and Trade of the Russian Federation, held a meeting to discuss the support measures for manufacturers of equipment that can be used in the pharmaceutical industry. To achieve these goals, Russian companies can benefit from a wide range of existing state support measures described by Vasily Osmakov during the meeting.
Clearside Biomedical, Inc. Announces Fourth Quarter And Full Year 2016 Financial Results
14 March 2017
Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, today reported financial results for the fourth quarter and full year ended December 31, 2016 , and provided an update on its development programs.
Global respiratory complications market will surpass $30 billion mark by 2022, says GBI Research
14 March 2017
The respiratory complications market is set to grow from $21.8 billion in 2015 to $30.2 billion by 2022, representing a compound annual growth rate of 4.7%, according to business intelligence provider GBI Research.
22% of Russian pharmaceutical manufacturers received GMP certificate
14 March 2017
According to the analytical department of FBI SID&GP, by the end of 2016, 527 manufacturing licenses were effective in the Russian Federation, which corresponds to 566 production sites in 71 regions. At the same time, 378 sites (69%) have a license for manufacturing and packaging of finished dosage forms and substances, while 185 sites (31%) produce only alcohol-containing solutions, medical gases, etc.
Marinus Pharmaceuticals Provides Business Update and 2016 Financial Results
13 March 2017
Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today provided a business update on its clinical development activities and reported its financial results for the year ended December 31, 2016.
The new CEOs in biopharma are joining the big players at the billion-dollar chip table
13 March 2017
Every time a new CEO takes over at a biopharma company of some size, the instinctive response is to look for some deal or deals that will help set the tone for the new leader, preferably one that is predictive of a bold — but not reckless — design on future growth.
High U.S. drug prices cover pharma's global R&D—and a whole lot more, study finds
13 March 2017
Sure to add fuel to the fiery U.S. drug pricing debate, new work from several health policy experts showed that pharma makes more from platinum pricing in the U.S. than it spends on research around the world.
Pfizer looks at building major gene therapy manufacturing facility in North Carolina
10 March 2017
Pfizer, which scooped up Bamboo Therapeutics last year in its aim to be a major player in gene therapies, is now looking at building a gene therapy production facility in North Carolina where the biotech is based.
Artificial intelligence for medicine and neurocomputers—international effort
10 March 2017
An international research team has come up with a self-learning artificial intelligence, a breakthrough that may have wide applications, including therapies to treat human memory dysfunctions. The key participant in the project is the Tomsk State University (TSU). Other developers also include researchers from Germany, Bulgaria, Ukraine, Belarus, and Kazakhstan.
EU and US Pledge to Recognize Each Other’s GMP Inspections
09 March 2017
In a landmark decision, the United States FDA and the European Commission announced on March 2, 2017 that they will recognize each other’s inspection assessments at pharmaceutical manufacturing facilities. The Mutual Recognition Agreement amends the 1998 agreement on good manufacturing practices and comes three years after initial discussions began.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024